NO942095L - Imidazopyridiner - Google Patents

Imidazopyridiner

Info

Publication number
NO942095L
NO942095L NO942095A NO942095A NO942095L NO 942095 L NO942095 L NO 942095L NO 942095 A NO942095 A NO 942095A NO 942095 A NO942095 A NO 942095A NO 942095 L NO942095 L NO 942095L
Authority
NO
Norway
Prior art keywords
well
imidazopyridines
aldosteronism
angiotensin
salts
Prior art date
Application number
NO942095A
Other languages
English (en)
Norwegian (no)
Other versions
NO942095D0 (no
Inventor
Mathias Osswald
Werner Mederski
Dieter Dorsch
Pierre Schelling
Norbert Beier
Ingeborg Lues
Klaus-Otto Minck
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO942095D0 publication Critical patent/NO942095D0/no
Publication of NO942095L publication Critical patent/NO942095L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO942095A 1993-06-07 1994-06-06 Imidazopyridiner NO942095L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4318813A DE4318813A1 (de) 1993-06-07 1993-06-07 Imidazopyridine

Publications (2)

Publication Number Publication Date
NO942095D0 NO942095D0 (no) 1994-06-06
NO942095L true NO942095L (no) 1994-12-08

Family

ID=6489765

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942095A NO942095L (no) 1993-06-07 1994-06-06 Imidazopyridiner

Country Status (16)

Country Link
US (1) US5438063A (fa)
EP (1) EP0628556A1 (fa)
JP (1) JPH072854A (fa)
KR (1) KR950000697A (fa)
CN (1) CN1100721A (fa)
AU (1) AU689468B2 (fa)
CA (1) CA2125077A1 (fa)
CZ (1) CZ137694A3 (fa)
DE (1) DE4318813A1 (fa)
HU (1) HUT71483A (fa)
NO (1) NO942095L (fa)
PL (1) PL303715A1 (fa)
RU (1) RU94019981A (fa)
SK (1) SK67794A3 (fa)
TW (1) TW269689B (fa)
ZA (1) ZA943996B (fa)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2708612B1 (fr) * 1993-08-05 1996-03-01 Roussel Uclaf Nouveaux dérivés bicycliques de l'imidazole, leur procédé de préparation, les nouveaux intermédiaires obtenus, leur application à titre de médicaments et les compositions pharmaceutiques les renfermant.
DE4432860A1 (de) * 1994-09-15 1996-03-21 Merck Patent Gmbh Imidazopyridine
PT930076E (pt) * 1996-07-15 2005-01-31 Sankyo Co Composicoes medicinais
DE19845153A1 (de) * 1998-10-01 2000-04-06 Merck Patent Gmbh Imidazo[4,5]-pyridin-4-on-derivate
GB0215293D0 (en) 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
EP1558581A4 (en) 2002-10-07 2007-07-25 Bristol Myers Squibb Co DERIVATIVES OF TRIAZOLONE AND TRIAZOLETHIONE
EP1706403B9 (en) 2003-12-22 2012-07-25 K.U.Leuven Research & Development Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment
US20060252791A1 (en) 2004-12-21 2006-11-09 Gilead Sciences, Inc. Imidazo[4,5-c]pyridine compound and method of antiviral treatment
HRP20080552A9 (en) * 2005-03-30 2009-08-31 Takeda Pharmaceutical Company Limited Benzimidazole derivative and use thereof
TWI360549B (en) 2006-07-07 2012-03-21 Gilead Sciences Inc Novel pyridazine compound and use thereof
UA99466C2 (en) 2007-07-06 2012-08-27 Гилиад Сайенсиз, Инк. Crystalline pyridazine compound
JP2011526881A (ja) * 2008-06-25 2011-10-20 ファイザー・インク ジアリール化合物およびそれらの使用
WO2009158309A2 (en) * 2008-06-25 2009-12-30 Ligand Pharmaceuticals Inc. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
JP5528339B2 (ja) 2008-07-08 2014-06-25 株式会社カネカ α−ヘテロ置換アルキルハロヒドロシランの製造方法およびその利用
CZ306650B6 (cs) * 2011-03-04 2017-04-19 Zentiva, K.S. Způsob výroby 2-ethoxy-1-((2´-((hydroxyamino)iminomethyl)bifenyl-4-yl)methyl)-1H-benzo[d]imidazol-7-karboxylové kyseliny a jejích esterů, klíčových intermediátů syntézy azilsartanu
US9617246B2 (en) 2013-12-18 2017-04-11 Merck Sharp & Dohme Corp. Thioether-piperidinyl orexin receptor antagonists
CN105669495A (zh) * 2014-11-21 2016-06-15 重庆朗天制药有限公司 一种阿奇沙坦及其中间体新的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
US5332744A (en) * 1989-05-30 1994-07-26 Merck & Co., Inc. Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists
US5223499A (en) * 1989-05-30 1993-06-29 Merck & Co., Inc. 6-amino substituted imidazo[4,5-bipyridines as angiotensin II antagonists
EP0430709A3 (en) * 1989-12-01 1992-02-12 Glaxo Group Limited Benzthiophen derivatives
DE4110019C2 (de) * 1991-03-27 2000-04-13 Merck Patent Gmbh Imidazopyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd Biphenyl substituted heterocyclic compounds their production and pharmaceutical compositions comprising them
DE4141788A1 (de) * 1991-12-18 1993-06-24 Merck Patent Gmbh Imidazopyridine
DE4305602A1 (de) * 1992-06-17 1993-12-23 Merck Patent Gmbh Imidazopyridine

Also Published As

Publication number Publication date
JPH072854A (ja) 1995-01-06
SK67794A3 (en) 1995-02-08
NO942095D0 (no) 1994-06-06
AU6348794A (en) 1994-12-08
KR950000697A (ko) 1995-01-03
CZ137694A3 (en) 1994-12-15
RU94019981A (ru) 1996-06-10
CA2125077A1 (en) 1994-12-08
PL303715A1 (en) 1995-01-09
AU689468B2 (en) 1998-04-02
DE4318813A1 (de) 1994-12-08
EP0628556A1 (de) 1994-12-14
US5438063A (en) 1995-08-01
CN1100721A (zh) 1995-03-29
HUT71483A (en) 1995-11-28
TW269689B (fa) 1996-02-01
ZA943996B (en) 1995-02-06
HU9401692D0 (en) 1994-09-28

Similar Documents

Publication Publication Date Title
NO944689L (no) Imidazopyrider
NO942095L (no) Imidazopyridiner
NO991951L (no) Tienopyrimidiner med fosfodiesterase V-inhiberende virkning
CA2063926A1 (en) Imidazopyridine
GR3029853T3 (en) Diazabicyclic neurokinin antagonists
NO20002702L (no) Tienopyrimidiner
NO20002958L (no) Benzamidinderivater som koagulasjonsfaktor Xa-hemmere
MY107157A (en) Quinuclidine derivatives.
NO20021083L (no) Pyrazolo[4,3-d]pyrimidiner
MY121967A (en) New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
NO20013384L (no) Imidazo[4,5-c]pyridin-4-on-derivater
MY130736A (en) Imidazo(4,5-c) pyridin-4-one derivatives
NO20016201L (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
RU94039284A (ru) Производные пиперазина, способ их получения, фармкомпозиция и ее использование
CA2014062A1 (en) Pyridine derivatives
DE69116788D1 (de) 4-substituierte Dihydropyrido [4,3-d] pyrimidine als Analgetika und entzündungshemmende Mittel zur topischen Anwendung bei der Behandlung von Hauterkrankungen
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
EP0348527A4 (en) Antiallergic eye drop
MX9306563A (es) Derivados de imidazopiridinas, proceso para su preparacion y formulaciones farmaceuticas que los contienen.
EP0222578A3 (en) Use of cyclic somatostatin analogues in the treatment of immediate hypersensitivity diseases
NO20021310L (no) Aminderivater
DE69015411D1 (de) 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one und -thione und deren Verwendung bei der Vorbeugung und und Behandlung von AIDS.
RU93048331A (ru) Имидазопиридины, способ их получения, фармацевтическая композиция и способ ее получения, способ лечения
DK177191D0 (da) Heterocyclic compounds and their preparation and use
UA27753C2 (uk) Похідні піридонбіфенілу та їх солі